Terms: = Lymphoma AND LYL1, P12980, 4066, ENSG00000104903 AND Diagnosis
5 results:
1. Risk factors for severe infections in secondary immunodeficiency: a retrospective US administrative claims study in patients with hematological malignancies.
Jolles S; Smith BD; Vinh DC; Mallick R; Espinoza G; DeKoven M; Divino V
Leuk Lymphoma; 2022 Jan; 63(1):64-73. PubMed ID: 34702119
[TBL] [Abstract] [Full Text] [Related]
2. Recurrent finding of the FIP1L1-PDGFRA fusion gene in eosinophilia-associated acute myeloid leukemia and lymphoblastic T-cell lymphoma.
Metzgeroth G; Walz C; Score J; Siebert R; Schnittger S; Haferlach C; Popp H; Haferlach T; Erben P; Mix J; Müller MC; Beneke H; Müller L; Del Valle F; Aulitzky WE; Wittkowsky G; Schmitz N; Schulte C; Müller-Hermelink K; Hodges E; Whittaker SJ; Diecker F; Döhner H; Schuld P; Hehlmann R; Hochhaus A; Cross NC; Reiter A
Leukemia; 2007 Jun; 21(6):1183-8. PubMed ID: 17377585
[TBL] [Abstract] [Full Text] [Related]
3. Precursor T-cell acute lymphoblastic leukemia/lymphoblastic lymphoma and acute biphenotypic leukemias.
Han X; Bueso-Ramos CE
Am J Clin Pathol; 2007 Apr; 127(4):528-44. PubMed ID: 17369128
[TBL] [Abstract] [Full Text] [Related]
4. Does the assessment of serum markers in patients with lung cancer aid in the clinical decision making process?
Ebert W; Muley T; Drings P
Anticancer Res; 1996; 16(4B):2161-8. PubMed ID: 8694537
[TBL] [Abstract] [Full Text] [Related]
5. Heterogeneity of t(1;19)(q23;p13) acute leukaemias. French Haematological Cytology Group.
Troussard X; Rimokh R; Valensi F; Leboeuf D; Fenneteau O; Guitard AM; Manel AM; Schillinger F; Leglise C; Brizard A
Br J Haematol; 1995 Mar; 89(3):516-26. PubMed ID: 7734349
[TBL] [Abstract] [Full Text] [Related]
